ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,822.93
-0.28%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Voyager Therapeutics Inc (VYGR)

  7. Voyager Therapeutics Inc (VYGR) 뉴스

VYGR Voyager Therapeutics Inc

8.81
0.28 (3.28%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Voyager Therapeutics Inc VYGR 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.28 3.28% 8.81 13:00:09
개장가 저가 고가 종가 전일 종가
8.76 8.61 8.92 8.81 8.53
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/04/202405:30GLOBEVoyager Therapeutics to Present Broad Set of Translational..
16/04/202420:00GLOBEVoyager Therapeutics Announces Selection of Development..
27/03/202405:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
13/03/202420:00GLOBEVoyager Therapeutics Announces Appointment of Toby Ferguson..
29/02/202406:01GLOBEVoyager Therapeutics Reports Fourth Quarter and Full Year..
29/02/202406:00EDGAR2Form 8-K - Current report
26/02/202421:00GLOBEVoyager Therapeutics Announces Selection of Gene Therapy..
23/02/202406:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202405:16EDGAR2Form 144 - Report of proposed sale of securities
22/02/202405:13EDGAR2Form 144 - Report of proposed sale of securities
21/02/202421:00GLOBEVoyager Therapeutics Announces Fourth Quarter 2023..
21/02/202405:11EDGAR2Form 144 - Report of proposed sale of securities
20/02/202421:00GLOBEVoyager Therapeutics Reports Robust Preclinical Activity in..
17/02/202407:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202421:00GLOBEVoyager Therapeutics to Present at the Oppenheimer Annual..
20/01/202406:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/01/202406:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202406:20EDGAR2Form D - Notice of Exempt Offering of Securities
18/01/202405:33EDGAR2Form 144 - Report of proposed sale of securities
18/01/202405:21EDGAR2Form 144 - Report of proposed sale of securities
09/01/202406:49EDGAR2Form 8-K - Current report
09/01/202406:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/01/202412:45GLOBEVoyager Therapeutics Announces Pricing of Public Offering
05/01/202407:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/01/202406:14GLOBEVoyager Therapeutics Announces Proposed Public Offering
03/01/202421:00GLOBEVoyager Therapeutics to Present at the 42nd Annual J.P...
02/01/202421:46DJNVoyager Therapeutics Shares Leap Premarket on Novartis..
02/01/202421:05EDGAR2Form 8-K - Current report
02/01/202421:00GLOBEVoyager Therapeutics Enters Capsid License Agreement and..
06/12/202321:04EDGAR2Form 8-K - Current report
06/12/202321:00GLOBEVoyager Therapeutics Announces Selection of Development..
07/11/202306:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:01GLOBEVoyager Therapeutics Reports Third Quarter 2023 Financial..
07/11/202306:00EDGAR2Form 8-K - Current report
30/10/202320:00GLOBEVoyager Therapeutics Announces Third Quarter 2023 Conference..
03/10/202305:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/09/202320:00GLOBEVoyager Therapeutics to Present at the Chardan Genetic..
19/09/202305:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/09/202302:57EDGAR2Form 144 - Report of proposed sale of securities
08/09/202305:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
30/08/202320:00GLOBEVoyager Therapeutics to Participate in Upcoming Investor..
17/08/202305:18EDGAR2Form 8-K - Current report
09/08/202305:01GLOBEVoyager Therapeutics Announces Inducement Grants Under..
07/08/202321:00GLOBEVoyager Therapeutics Announces Appointment of Beth Shafer as..
03/08/202320:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/08/202320:00EDGAR2Form 8-K - Current report
03/08/202320:00GLOBEVoyager Therapeutics Reports Second Quarter 2023 Financial..

최근 히스토리

NASDAQ
VYGR
Voyager Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유